Statement on FTC’s Win in Lawsuit Against the Makers of Dietary Supplement Prevagen

News Healthcare & Pharma Statements & Speeches

Date: 10th Dec, 2024 Source: Federal Trade Commission Country: USA Original Source

Brief

"On October 12, 2024, the Federal Trade Commission issued an update regarding Statement on FTC's Win in Lawsuit Against the Makers of Dietary Supplement Prevagen. The U.S. District Court for the Southern District of New York ordered Quincy Bioscience to cease making deceptive claims about Prevagen that mislead Americans concerned about memory loss. This ruling marks another win in the FTC's efforts to protect older Americans and promote reliable scientific evidence behind health claims."

This content is restricted.

Highlights content goes here...

This content is restricted.

Federal Trade Commission

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Statement on FTC’s Win in Lawsuit Against the Makers of Dietary Supplement Prevagen

Brief

Federal Trade Commission

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Statement on FTC’s Win in Lawsuit Against the Makers of Dietary Supplement Prevagen

Brief

Federal Trade Commission

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.